Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
07 2022
Historique:
received: 16 09 2021
accepted: 08 06 2022
pubmed: 22 7 2022
medline: 27 7 2022
entrez: 21 7 2022
Statut: ppublish

Résumé

Early recognition and treatment of sepsis are linked to improved patient outcomes. Machine learning-based early warning systems may reduce the time to recognition, but few systems have undergone clinical evaluation. In this prospective, multi-site cohort study, we examined the association between patient outcomes and provider interaction with a deployed sepsis alert system called the Targeted Real-time Early Warning System (TREWS). During the study, 590,736 patients were monitored by TREWS across five hospitals. We focused our analysis on 6,877 patients with sepsis who were identified by the alert before initiation of antibiotic therapy. Adjusting for patient presentation and severity, patients in this group whose alert was confirmed by a provider within 3 h of the alert had a reduced in-hospital mortality rate (3.3%, confidence interval (CI) 1.7, 5.1%, adjusted absolute reduction, and 18.7%, CI 9.4, 27.0%, adjusted relative reduction), organ failure and length of stay compared with patients whose alert was not confirmed by a provider within 3 h. Improvements in mortality rate (4.5%, CI 0.8, 8.3%, adjusted absolute reduction) and organ failure were larger among those patients who were additionally flagged as high risk. Our findings indicate that early warning systems have the potential to identify sepsis patients early and improve patient outcomes and that sepsis patients who would benefit the most from early treatment can be identified and prioritized at the time of the alert.

Identifiants

pubmed: 35864252
doi: 10.1038/s41591-022-01894-0
pii: 10.1038/s41591-022-01894-0
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1455-1460

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Rhee, C. et al. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw. Open 2, e187571–e187571 (2019).
pubmed: 30768188 pmcid: 6484603 doi: 10.1001/jamanetworkopen.2018.7571
Riedemann, N. C., Guo, R. F. & Ward, P. A. The enigma of sepsis. J. Clin. Invest. 112, 460–467 (2003).
pubmed: 12925683 pmcid: 171398 doi: 10.1172/JCI200319523
Marshall, J. C. Why have clinical trials in sepsis failed? Trends Mol. Med. 20, 195–203 (2014).
pubmed: 24581450 doi: 10.1016/j.molmed.2014.01.007
Rhodes, A. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit. Care Med. 43, 304–377 (2017).
Kumar, A. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34, 1589–1596 (2006).
pubmed: 16625125 doi: 10.1097/01.CCM.0000217961.75225.E9
Ferrer, R. et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit. Care Med. 42, 1749–1755 (2014).
pubmed: 24717459 doi: 10.1097/CCM.0000000000000330
Liu, V. X. et al. The timing of early antibiotics and hospital mortality in sepsis. Am. J. Respir. Crit. Care Med. 196, 856–863 (2017).
pubmed: 28345952 pmcid: 5649973 doi: 10.1164/rccm.201609-1848OC
Peltan, I. D. et al. ED door-to-antibiotic time and long-term mortality in sepsis. Chest 155, 938–946 (2019).
pubmed: 30779916 pmcid: 6533450 doi: 10.1016/j.chest.2019.02.008
Chamberlain, D. J., Willis, E. M. & Bersten, A. B. The severe sepsis bundles as processes of care: a meta-analysis. Aust. Crit. Care 24, 229–243 (2011).
pubmed: 21324711 doi: 10.1016/j.aucc.2011.01.003
Damiani, E. et al. Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS ONE 10, e0125827 (2015).
pubmed: 25946168 pmcid: 4422717 doi: 10.1371/journal.pone.0125827
Giannini, H. M. et al. A machine learning algorithm to predict severe sepsis and septic shock: development, implementation, and impact on clinical practice. Crit. Care Med. 47, 1485–1492 (2019).
pubmed: 31389839 pmcid: 8635476 doi: 10.1097/CCM.0000000000003891
Desautels, T. et al. Prediction of sepsis in the intensive care unit with minimal electronic health record data: a machine learning approach. JMIR Med. Inform. 4, 1–15 (2016).
doi: 10.2196/medinform.5909
Shashikumar, S. P., Josef, C. S., Sharma, A. & Nemati, S. DeepAISE—an interpretable and recurrent neural survival model for early prediction of sepsis. Artif. Intell. Med. 113, 102036 (2021).
pubmed: 33685592 pmcid: 8029104 doi: 10.1016/j.artmed.2021.102036
Horng, S. et al. Creating an automated trigger for sepsis clinical decision support at emergency department triage using machine learning. PLoS ONE 12, e0174708 (2017).
pubmed: 28384212 pmcid: 5383046 doi: 10.1371/journal.pone.0174708
Bedoya, A. D. et al. Machine learning for early detection of sepsis: an internal and temporal validation study. JAMIA Open 3, 252–260 (2020).
pubmed: 32734166 pmcid: 7382639 doi: 10.1093/jamiaopen/ooaa006
Shimabukuro, D. W., Barton, C. W., Feldman, M. D., Mataraso, S. J. & Das, R. Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. BMJ Open Respir. Res. 4, e000234 (2017).
pubmed: 29435343 pmcid: 5687546 doi: 10.1136/bmjresp-2017-000234
McCoy, A. & Das, R. Reducing patient mortality, length of stay and readmissions through machine learning-based sepsis prediction in the emergency department, intensive care unit and hospital floor units. BMJ Open Qual. 6, e000158 (2017).
pubmed: 29450295 pmcid: 5699136 doi: 10.1136/bmjoq-2017-000158
Escobar, G. J. et al. Automated identification of adults at risk for in-hospital clinical deterioration. N. Engl. J. Med. 383, 1951–1960 (2020).
pubmed: 33176085 pmcid: 7787261 doi: 10.1056/NEJMsa2001090
Topiwala, R., Patel, K., Twigg, J., Rhule, J. & Meisenberg, B. Retrospective observational study of the clinical performance characteristics of a machine learning approach to early sepsis identification. Crit. Care Explor. 1, e0046 (2019).
pubmed: 32166288 pmcid: 7063939 doi: 10.1097/CCE.0000000000000046
Ginestra, J. C. et al. Clinician perception of a machine learning-based early warning system designed to predict severe sepsis and septic shock. Crit. Care Med. 47, 1477 (2019).
pubmed: 31135500 pmcid: 6791738 doi: 10.1097/CCM.0000000000003803
Henry, K. E., Hager, D. N., Pronovost, P. J. & Saria, S. A targeted real-time early warning score (TREWScore) for septic shock. Sci. Transl. Med. 7, 299ra122–299ra122 (2015).
pubmed: 26246167 doi: 10.1126/scitranslmed.aab3719
Henry, K. E. et al. Factors driving provider adoption of the TREWS machine-learning-based early warning system and its effects on sepsis treatment timing. Nat. Med. https://doi.org/10.1038/s41591-022-01895-z (2022).
Henry, K. E., Hager, D. N., Osborn, T. M., Wu, A. W. & Saria, S. Comparison of automated sepsis identification methods and electronic health record-based sepsis phenotyping: improving case identification accuracy by accounting for confounding comorbid conditions. Crit. Care Explor. 1, e0053 (2019).
pubmed: 32166234 pmcid: 7063888 doi: 10.1097/CCE.0000000000000053
Rhee, C. et al. Infectious diseases society of america position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure. Clin. Infect. Dis. 72, 541–552 (2021).
pubmed: 32374861 doi: 10.1093/cid/ciaa059
Seymour, C. W. et al. Time to treatment and mortality during mandated emergency care for sepsis. N. Engl. J. Med. 376, 2235–2244 (2017).
pubmed: 28528569 pmcid: 5538258 doi: 10.1056/NEJMoa1703058
Vanderweele, T. J., Luedtke, A. R., Van Der Laan, M. J. & Kessler, R. C. Selecting optimal subgroups for treatment using many covariates. Epidemiology 30, 334–341 (2019).
pubmed: 30789432 pmcid: 6456380 doi: 10.1097/EDE.0000000000000991
Manaktala, S. & Claypool, S. R. Evaluating the impact of a computerized surveillance algorithm and decision support system on sepsis mortality. J. Am. Med. inform. Assoc. 24, 88–95 (2017).
pubmed: 27225197 doi: 10.1093/jamia/ocw056
Burdick, H. et al. Effect of a sepsis prediction algorithm on patient mortality, length of stay and readmission: a prospective multicentre clinical outcomes evaluation of real-world patient data from US hospitals. BMJ Health Care Inform. 27, e100109 (2020).
pubmed: 32354696 pmcid: 7245419 doi: 10.1136/bmjhci-2019-100109
Guy, J. S., Jackson, E. & Perlin, J. B. Accelerating the clinical workflow using the sepsis prediction and optimization of therapy (SPOT) tool for real-time clinical monitoring. NEJM Catal. Innov. Care Deliv. https://doi.org/10.1056/CAT.19.1036 (2020).
Rosenbaum, P. R. & Briskman. Design of Observational Studies Vol. 10 (Springer, 2010).
Hernán, M. A. & Robins, J. M. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758–764 (2016).
pubmed: 26994063 pmcid: 4832051 doi: 10.1093/aje/kwv254
Wong, A. et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern. Med. 48109, 1–6 (2021).
Henry, K. E. et al. Human-machine teaming is key to AI adoption: clinicians’ experiences with a deployed machine learning system. NPJ Digit. Med. https://doi.org/10.1038/s41746-022-00597-7 (2022).
Saria, S. & Henry, K. E. Too many definitions of sepsis: Can machine learning leverage the electronic health record to increase accuracy and bring consensus? Crit. Care Med. 48, 137–141 (2020). https://doi.org/10.1097/CCM.0000000000004144
Rhee, C. et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw. Open 3, e202899 (2020).
pubmed: 32297949 pmcid: 7163409 doi: 10.1001/jamanetworkopen.2020.2899
Jordan, M. I. & Jacobs, R. A. Hierarchical mixtures of experts and the EM algorithm. Proceedings of International Conference on Neural Networks 2, 1339–1344 (1993).
Seymour, C. W. et al. Assessment of clinical criteria for sepsis for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315, 762–774 (2016).
pubmed: 26903335 pmcid: 5433435 doi: 10.1001/jama.2016.0288
Rhee, C., Dantes, R. B., Epstein, L. & Klompas, M. Using objective clinical data to track progress on preventing and treating sepsis: CDC’s new adult sepsis event surveillance strategy. BMJ Qual. Saf. 28, 305–309 (2019).
pubmed: 30254095 doi: 10.1136/bmjqs-2018-008331
Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intens. Care Med. 22, 707–710 (1996).
doi: 10.1007/BF01709751
Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J. E. APACHE II: a severity of disease classification system. Crit. Care Med. 13, 818–829 (1985).
pubmed: 3928249 doi: 10.1097/00003246-198510000-00009
Norton, E. C., Miller, M. M. & Kleinman, L. C. Computing adjusted risk ratios and risk differences in Stata. Stata J. 13, 492–509 (2013).
doi: 10.1177/1536867X1301300304
Peng, L. Quantile regression for survival data. Annu. Rev. Stat. Its Appl. 8, 413–437 (2021).
doi: 10.1146/annurev-statistics-042720-020233
Seabold, S. & Perktold, J. statsmodels: econometric and statistical modeling with python. In van der Walt, S. & Millman, J. (Eds.) Proc. 9th Python in Science Conference 92–96 (2010).
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
Horvitz, D. G. & Thompson, D. J. A generalization of sampling without replacement from a finite universe. J. Am. Stat. Assoc. 47, 663–685 (1952).
doi: 10.1080/01621459.1952.10483446
Robins, J. M. Marginal structural models versus structural nested models as tools for causal inference. In Halloran, M. E. & Berry, D. (Eds.) Statistical Models in Epidemiology, the Environment, and Clinical Trials 95–133 (Springer, 2000).
Hernán, M. A. & Robins, J. M. Causal Inference: What If (Chapman & Hall/CRC, 2020).
Lee, B. K., Lessler, J. & Stuart, E. A. Weight trimming and propensity score weighting. PLoS ONE 6, e18174 (2011).
pubmed: 21483818 pmcid: 3069059 doi: 10.1371/journal.pone.0018174
World Health Organization. ICD-10 : international statistical classification of diseases and related health problems : tenth revision (World Health Organization, 2004).

Auteurs

Roy Adams (R)

Malone Center for Engineering in Healthcare, Johns Hopkins University, Baltimore, MD, USA.
Department of Psychiatry and Behavioral Science, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Katharine E Henry (KE)

Department of Psychiatry and Behavioral Science, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA.

Anirudh Sridharan (A)

Howard County General Hospital, Columbia, MD, USA.

Hossein Soleimani (H)

Health Informatics, University of California, San Francisco, CA, USA.

Andong Zhan (A)

Department of Psychiatry and Behavioral Science, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA.

Nishi Rawat (N)

Armstrong Institute for Patient Safety and Quality, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Lauren Johnson (L)

Department of Quality Improvement, Johns Hopkins Hospital, Baltimore, MD, USA.

David N Hager (DN)

Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Sara E Cosgrove (SE)

Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Andrew Markowski (A)

Suburban Hospital, Bethesda, MD, USA.

Eili Y Klein (EY)

Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Edward S Chen (ES)

Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Mustapha O Saheed (MO)

Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Maureen Henley (M)

Department of Quality Improvement, Johns Hopkins Hospital, Baltimore, MD, USA.

Sheila Miranda (S)

Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.

Katrina Houston (K)

Department of Quality Improvement, Johns Hopkins Hospital, Baltimore, MD, USA.

Robert C Linton (RC)

Howard County General Hospital, Columbia, MD, USA.

Anushree R Ahluwalia (AR)

Department of Quality Improvement, Johns Hopkins Hospital, Baltimore, MD, USA.

Albert W Wu (AW)

Armstrong Institute for Patient Safety and Quality, Johns Hopkins School of Medicine, Baltimore, MD, USA. awu@jhu.edu.
Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. awu@jhu.edu.
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. awu@jhu.edu.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. awu@jhu.edu.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. awu@jhu.edu.

Suchi Saria (S)

Malone Center for Engineering in Healthcare, Johns Hopkins University, Baltimore, MD, USA. ssaria@cs.jhu.edu.
Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA. ssaria@cs.jhu.edu.
Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. ssaria@cs.jhu.edu.
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. ssaria@cs.jhu.edu.
Bayesian Health, New York, NY, USA. ssaria@cs.jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH